ERBELLA Successfully Concludes Participation at KAAD 2025 Summer Conference – Spotlight on PLA Skin Booster ‘ERBELLA PLA PLUS AQ’
Writer 최고관리자
2025-08-22
ERBELLA, the premium medical aesthetics brand by USCarePharm, announced its successful participation in the 15th Annual Summer Conference of the Korean Academy of Aesthetic and Anti-Aging Dermatology (KAAD), held on August 10 at Seoul Dragon City Hotel.
KAAD is a highly respected academic society comprised of board-certified dermatologists in Korea, setting authoritative guidelines for anti-aging treatments including botulinum toxin and filler procedures. This year’s summer conference featured a comprehensive program covering basic science, advanced techniques, clinical applications, and emerging practices, designed to enhance the expertise of participating physicians.
Showcasing ERBELLA’s Skin Booster Line
At the event, ERBELLA unveiled its innovative liquid PLLA skin booster, ERBELLA PLA Plus AQ, alongside a lineup of boosters tailored to diverse skin concerns. The booth drew strong interest with engaging activities such as product preference surveys, brand quizzes, and prize events, further amplifying audience engagement.
Over 200 dermatologists participated in the product survey, demonstrating significant interest in ERBELLA’s portfolio. Among the highlights were:
ERBELLA NMN – improves skin texture with NMN-based anti-aging benefits
Melathion – a brightening solution for pigmentation care
Anti-AC PTT – acne solution leveraging patented Theramogen AT for anti-inflammatory efficacy
ExoRN – a regenerative booster combining exosomes and PDRN
Spotlight on ERBELLA PLA Plus AQ
The most inquired-about product of the day was ERBELLA PLA Plus AQ, the world’s first commercialized liquid PLLA skin booster. Developed using USCarePharm’s patented technology, this product eliminates the need for a separate reconstitution process and features uniformly porous PLLA particles. These properties enhance cell adhesion, improve skin texture, and provide lasting hydration, positioning ERBELLA PLA Plus AQ as a breakthrough in skin rejuvenation.
Advancing K-Anti-Aging Solutions
“Through this conference, we were able to share the latest developments in anti-aging research with Korean dermatologists and exchange valuable clinical insights,” said an ERBELLA representative.
“Moving forward, ERBELLA will continue to provide trusted K-Anti-Aging solutions and pioneer a new paradigm in aesthetic medicine.”
Expanding Global Footprint
Following the KAAD conference, ERBELLA is set to participate in InterCHARM Russia and Beautyworld Middle East (Dubai) this October. With continuous product innovation and global marketing initiatives, the brand aims to strengthen its position as a leading player in the international medical aesthetics market.
KAAD is a highly respected academic society comprised of board-certified dermatologists in Korea, setting authoritative guidelines for anti-aging treatments including botulinum toxin and filler procedures. This year’s summer conference featured a comprehensive program covering basic science, advanced techniques, clinical applications, and emerging practices, designed to enhance the expertise of participating physicians.
Showcasing ERBELLA’s Skin Booster Line
At the event, ERBELLA unveiled its innovative liquid PLLA skin booster, ERBELLA PLA Plus AQ, alongside a lineup of boosters tailored to diverse skin concerns. The booth drew strong interest with engaging activities such as product preference surveys, brand quizzes, and prize events, further amplifying audience engagement.
Over 200 dermatologists participated in the product survey, demonstrating significant interest in ERBELLA’s portfolio. Among the highlights were:
ERBELLA NMN – improves skin texture with NMN-based anti-aging benefits
Melathion – a brightening solution for pigmentation care
Anti-AC PTT – acne solution leveraging patented Theramogen AT for anti-inflammatory efficacy
ExoRN – a regenerative booster combining exosomes and PDRN
Spotlight on ERBELLA PLA Plus AQ
The most inquired-about product of the day was ERBELLA PLA Plus AQ, the world’s first commercialized liquid PLLA skin booster. Developed using USCarePharm’s patented technology, this product eliminates the need for a separate reconstitution process and features uniformly porous PLLA particles. These properties enhance cell adhesion, improve skin texture, and provide lasting hydration, positioning ERBELLA PLA Plus AQ as a breakthrough in skin rejuvenation.
Advancing K-Anti-Aging Solutions
“Through this conference, we were able to share the latest developments in anti-aging research with Korean dermatologists and exchange valuable clinical insights,” said an ERBELLA representative.
“Moving forward, ERBELLA will continue to provide trusted K-Anti-Aging solutions and pioneer a new paradigm in aesthetic medicine.”
Expanding Global Footprint
Following the KAAD conference, ERBELLA is set to participate in InterCHARM Russia and Beautyworld Middle East (Dubai) this October. With continuous product innovation and global marketing initiatives, the brand aims to strengthen its position as a leading player in the international medical aesthetics market.
관련자료
-
링크
-
첨부등록일 2025.08.22 16:20
-
Prev
-
Next